Prostate cancer
Results
Phase 3
This trial looked at a drug called ipilimumab for prostate cancer that was no longer responding to hormone therapy.
It was for men who only had mild symptoms, or no symptoms at all. And who hadn’t had chemotherapy.
Recruitment start: 1 October 2010
Recruitment end: 13 June 2012
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Robert Jones
Bristol-Myers Squibb
Experimental Cancer Medicine Centre (ECMC)
Last reviewed: 01 Aug 2017
CRUK internal database number: 7174
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
